Tumor immune response and immunotherapy in gastric cancer
Remarkable developments in immuno-oncology have changed the landscape of gastric cancer (GC) treatment. Because immunotherapy intervenes with tumor immune response rather than directly targeting tumor cells, it is important to develop a greater understanding of tumor immunity. This review paper summ...
Saved in:
Main Authors: | Yoonjin Kwak (Author), An Na Seo (Author), Hee Eun Lee (Author), Hye Seung Lee (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
by: Hye Jung Hwang, et al.
Published: (2020) -
A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer
by: Xiang Xu, et al.
Published: (2022) -
Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists
by: Soomin Ahn, et al.
Published: (2024) -
A standardized pathology report for gastric cancer: 2nd edition
by: Young Soo Park, et al.
Published: (2023) -
Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment
by: Zihan Xu, et al.
Published: (2024)